Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 9 0
Δ9-Tetrahydrocannabinol Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Dec/05/2020 2 0
Famotidine Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/04/2020 2 2
Paritaprevir Potential treatment - theoretical effect Used to treat other disease Antiviral Dec/02/2020 4 0
Simeprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/02/2020 9 1
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/25/2020 19 5
Prednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/14/2020 4 0
Grazoprevir Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/04/2020 2 1
[((5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE)] Potential treatment - theoretical effect Experimental Antiviral Sep/02/2020 1 0
Streptolydigin Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/02/2020 1 0